Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Long-term Prognosis of Patients Who Contraindicated for Intravenous Thrombolysis in Acute Ischemic StrokeLong-term Prognosis of Patients Who Contraindicated for Intravenous Thrombolysis in Acute Ischemic Stroke

Other Titles
Long-term Prognosis of Patients Who Contraindicated for Intravenous Thrombolysis in Acute Ischemic Stroke
Authors
Bo-Yeon Lee오재상윤석만
Issue Date
2019
Publisher
대한뇌혈관외과학회
Keywords
Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Mechanical Thrombectomy; Mortality; Emergency Medical Services
Citation
Journal of Cerebrovascular and Endovascular Neurosurgery, v.21, no.2, pp.77 - 85
Journal Title
Journal of Cerebrovascular and Endovascular Neurosurgery
Volume
21
Number
2
Start Page
77
End Page
85
URI
https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/4919
ISSN
2234-8565
Abstract
Background : As intravenous thrombolysis (IVT) has very restricted inclusion criteria, eligible patients of IVT constitute a very small proportion and studies about their mortality are rare. The long-term mortality in a patients with contraindication of ineligible patients of IVT still under the debate. So, we investigated the proportion of patients with contraindication of IVT and the short and long-term mortality of them in AIS on emergency department comparing with the long-term effect of IVT in patients with moderate-to-severe stroke. Methods : Using acute stroke assessment indication registry & Health Insurance Review and Assessment Service database, a total of 5,407 patients with NIHSS≥5 were selected from a total of 169 acute stroke care hospital nationwide during October-December 2011 and March-June 2013. We divided AIS patients into two groups: 1) IVT group who received IVT within 4.5 hours, and 2) non-IVT group who did not receive the IVT because of contraindications. And we divided the subgroups according to the reason of contraindication of IVT. The 5-year survival rate of each group was assessed using Kaplan-Meyer survival analysis. Results : Of the 5,407 patients, a total of 1,027 (19%) patients who received IVT using r-tPA within 4.5 h after onset. Compared with the IVT group, hazard ratios of non-IVT group were 1.33 at 3 months, 1.53 at 1 year and 1.47 at 5 years (p<.001). A total of 4,380 patients did not receive IVT because of the following contraindications to IVT. 1) Time restriction: 3,378 (77.1 %) patients were admitted after 4.5 h following stroke onset, and 144 (3.3%) patients failed to determine the stroke onset time. 2) Mild symptoms:137 (3.1%) patients had rapid improvement or mild stroke on emergency room, 3) Bleeding diathesis or non-adjustable hypertension: 53 (1.2%) patients showed a bleeding tendency or severe hypertension. Compared with the IVT group, the subgroups of non-IVT group showed consistently high mortality during short and long term follow up. Mild symptom and bleeding diathesis or non-adjustable hypertension subgroup in the non-IVT group consistently showed the higher mortality than time restriction subgroup during the short and long-term follow-up (log-rank p<.001). Patients who had rapid improvement or mild stroke on emergency department had the higher mortality than time restriction group in short and long term follow up. Conclusion : The AIS patients with rapid improvement or mild stroke on emergency room had higher mortality than ineligible patients of IVT due to time restriction during the short and long-term follow-up. A further management and special support on emergency department is needed for these patients with initially mild stroke and rapid improvement in AIS to reduce the poor outcome.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Neurosurgery > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Yoon, Seok Mann photo

Yoon, Seok Mann
College of Medicine (Department of Neurosurgery)
Read more

Altmetrics

Total Views & Downloads

BROWSE